Bain Capital Life Sciences Investors, LLC Q4 2023 Filing
Filed February 13, 2024
Portfolio Value
$1043.3T
Holdings
27
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 3,577,267 | $263.3T | 25.23% | |
| 2 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $117.0T | 11.21% | |
| 3 | PHVSPHARVARIS N V | 3,904,319 | $109.5T | 10.50% | |
| 4 | IRONDISC MEDICINE INC | 1,332,545 | $77.0T | 7.38% | |
| 5 | MDGLMADRIGAL PHARMACEUTICALS INC | 324,619 | $75.1T | 7.20% | |
| 6 | YB4PSAVARA INC | 14,232,751 | $66.9T | 6.41% | |
| 7 | CABACABALETTA BIO INC | 2,000,000 | $45.4T | 4.35% | |
| 8 | ANNXANNEXON INC | 8,061,719 | $36.6T | 3.51% | |
| 9 | RVMDREVOLUTION MEDICINES INC | 1,112,396 | $31.9T | 3.06% | |
| 10 | TNGXTANGO THERAPEUTICS INC | 2,892,663 | $28.6T | 2.74% | |
| 11 | NTRANATERA INC | 400,197 | $25.1T | 2.40% | |
| 12 | SYRSSYROS PHARMACEUTICALS INC | 2,749,808 | $21.4T | 2.05% | |
| 13 | —MERSANA THERAPEUTICS INC | 8,663,673 | $20.1T | 1.93% | |
| 14 | SLDBSOLID BIOSCIENCES INC | 3,130,422 | $19.2T | 1.84% | |
| 15 | NRIXNURIX THERAPEUTICS INC | 1,822,883 | $18.8T | 1.80% | |
| 16 | MRNS*MARINUS PHARMACEUTICALS INC | 1,431,058 | $15.6T | 1.49% | |
| 17 | ASNSUSDX4 PHARMACEUTICALS INC | 16,915,784 | $14.2T | 1.36% | |
| 18 | ARQTARCUTIS BIOTHERAPEUTICS INC | 3,000,000 | $9.7T | 0.93% | |
| 19 | CCCCC4 THERAPEUTICS INC | 1,642,210 | $9.3T | 0.89% | |
| 20 | IVVDINVIVYD INC | 1,937,207 | $7.6T | 0.73% | |
| 21 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $7.6T | 0.73% | |
| 22 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $6.2T | 0.60% | |
| 23 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $6.0T | 0.57% | |
| 24 | TSVT*2SEVENTY BIO INC | 1,331,801 | $5.7T | 0.55% | |
| 25 | ACRSACLARIS THERAPEUTICS INC | 3,500,000 | $3.7T | 0.35% | |
| 26 | XLOXILIO THERAPEUTICS INC | 2,805,413 | $1.5T | 0.15% | |
| 27 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $313.0B | 0.03% |